106 Posts
Scientists are studying new ways to use DNA in the medical care setting, exploring a state-of-the-art gene-editing tool called CRISPR.
Research indicates that, compared to those who have never been diagnosed with cancer, long-term cancer survivors are at higher risk of developing severe symptoms from COVID-19.
Maurie Markman, MD suggests rethinking the use of four common terms used in the cancer care community.
Scientists developing new treatments for those with COVID-19 symptoms are turning to the same biomedicine that is playing an increasingly important role in treating cancer: monoclonal antibodies.
With the recent rollout of a new COVID-19 vaccine, cancer patients may wonder if one vaccine is better than the other.
Metastatic cancer accounts for up to 90 percent of all cancer deaths in the United States each year.
A potential victim in the collateral damage from the pandemic: clinical trials and their participation rates, which have also taken a hit because of COVID-19 fears.
Researchers hope that the two mRNA vaccines developed for COVID-19 are harbingers for new mRNA-based vaccines and treatments for cancer.
Find out how immunotherapy for cancer helps the immune system recognize and fight cancer, who’s a good candidate for it and where to get immunotherapy treatment.
Guidelines
The information contained in this blog is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in the blog is intended to be used for medical diagnosis or treatment of any illness, condition or disease.